Kairos Pharma
(NYSEMKT) KAPA
Kairos Pharma Financials at a Glance
Market Cap
$12.49M
Revenue (TTM)
$0.00
Net Income (TTM)
$5.45M
EPS (TTM)
$-0.30
P/E Ratio
-1.93
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$0.59
Volume
0
Open
$0.59
Price
$0.59
Volume
0
Open
$0.59
Previous Close
$0.59
Daily Range
$0.59 - $0.59
52-Week Range
$0.40 - $2.11
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$0.59
Volume
0
Open
$0.59
Previous Close
$0.59
Daily Range
$0.59 - $0.59
52-Week Range
$0.40 - $2.11
KAPA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kairos Pharma
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
John S. Yu, MD
Website
kairospharma.comHeadquarters
Los Angeles, CA 90064, US
KAPA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-92%
Return on Capital
-88%
Return on Assets
-83%
Earnings Yield
-51.81%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.49M
Shares Outstanding
21.41M
Volume
0
Short Interest
0.00%
Avg. Volume
507.00K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$5.57M
EBITDA
$5.29M
Operating Cash Flow
$3.44M
Capital Expenditure
$0.00
Free Cash Flow
$3.44M
Cash & ST Invst.
$4.49M
Total Debt
$0.00
Kairos Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$120.00K
+400.0%
Gross Margin
0.00%
N/A
Market Cap
$12.49M
N/A
Market Cap/Employee
$12.49M
N/A
Employees
1
N/A
Net Income
$1.36M
-39.3%
EBITDA
$1.32M
-64.2%
Quarterly Fundamentals
Net Cash
$4.49M
+253.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-83.29%
N/A
Return on Invested Capital
-87.87%
N/A
Free Cash Flow
$1.92M
-6.6%
Operating Cash Flow
$1.08M
+39.9%